• Abbott, Apple, Citi, Nexstar, Musk, OpenAI

  • Mar 5 2025
  • Durée: 38 min
  • Podcast

Abbott, Apple, Citi, Nexstar, Musk, OpenAI

  • Résumé

  • Updates from the CFPB and SEC in litigation challenging rules concerning credit-card late fees and climate disclosures are among key March catalysts that BI’s litigation and policy analysts are watching. The team also discusses Nexstar and broadcasters in court March 19 over FCC limits on TV- and radio-station ownership. We’re also watching a March 24 hearing to bar experts in suits alleging Abbott and Reckitt’s Mead Johnson infant formula caused necrotizing enterocolitis. Apple may face sanctions in Epic v. Apple for violating an injunction. We expect a ruling on Elon Musk and xAI’s bid for a preliminary injunction against Sam Altman and others seeking to halt OpenAI’s conversion to for-profit status. We also discussed bank capital rules and the impact of budget talks to the health-care sector and the Inflation Reduction Act.

    See omnystudio.com/listener for privacy information.

    Voir plus Voir moins

Ce que les auditeurs disent de Abbott, Apple, Citi, Nexstar, Musk, OpenAI

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.